CORRESP

November 10, 2020

U.S. Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

Attn: Abby Adams

 

  Re:

Organogenesis Holdings Inc. (the “Company”)

Registration Statement on Form S-1

File No. 333-249531

Acceleration Request

Requested Date: November 12, 2020

Requested Time: 4:00 p.m. Eastern Daylight Time

Ladies and Gentlemen:

As representatives of the several underwriters of the Company’s proposed public offering, we hereby join the Company’s request that the effective date of the above-referenced Registration Statement be accelerated so that the above-referenced Registration Statement will be declared effective at 4:00 p.m., Eastern Daylight Time, on November 12, 2020, or as soon thereafter as is practicable.

Pursuant to Rule 460 of the General Rules and Regulations of the Securities and Exchange Commission under the Securities Act of 1933, as amended, we wish to advise you that there will be distributed to each underwriter or dealer, who is reasonably anticipated to participate in the distribution of the security, as many copies of the proposed form of preliminary prospectus as appears to be reasonable to secure adequate distribution of the preliminary prospectus.

The undersigned advise that they have complied and will continue to comply, and that they have been informed by the participating underwriters and dealers that they have complied with and will continue to comply, with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.

[Remainder of Page Intentionally Left Blank]


Very truly yours,

As Representatives of the several Underwriters

 

MORGAN STANLEY & CO. LLC

 

By:  

/s/ Chirag Surti

 

Name: Chirag Surti

Title: Vice President

 

SVB LEERINK LLC

 

By:  

/s/ Michael Giaquinto

 

Name: Michael Giaquinto

Title: Senior Managing Director